Breast cancer anti-estrogen resistance 4 (BCAR4) gene produces a spliced lncRNA that has been firstly identified to be inversely associated with the development of resistance to anti-estrogens in breast cancer cells and poor disease-free survival (DFS) for recurrent breast cancer. This evidence concerns the gene BCAR4 and breast cancer.